Venture Capital

Adlai Nortye licenses its promising pan-RAS cancer inhibitor to ASK Pharm for Greater China in a deal valued at up to $230 million.

Goodix's new GR5410 chip uses Bluetooth 6.1 and Channel Sounding to enable ultra-secure, high-precision digital car keys that can defeat relay attacks.

Biomaterials firm Bolt Projects posts huge revenue gains and raises 2026 guidance, but a looming Nasdaq delisting threat casts a shadow on its future.

A major order for advanced semiconductor equipment will fuel a European firm's expansion, powering next-gen AI data centers and LiDAR systems.

As pharma moves beyond small molecules, a new integrated platform helps developers navigate the challenges of PROTACs, peptides, and antibody drugs.

An FDA setback for its new mastitis drug prompts ImmuCell to double down on its profitable calf health franchise, First Defense®, in a major strategic shift.

Modular innovator Boxabl has secured a pivotal commercial license in California, fueling its expansion and pivot to commercial projects ahead of a SPAC merger.

Croatian firm Orqa is building a global network to produce one million drones annually, challenging market leaders and securing allied defense supply chains.

Swisslog Healthcare appoints Maria Garces from competitor Omnicell as VP, signaling an aggressive push to innovate and dominate the health tech market.

Mirum raises over a quarter-billion dollars to acquire Bluejay Therapeutics, targeting a high-potential liver disease drug and signaling major growth.

A landmark executive order reclassifying cannabis is set to unleash a wave of biopharma innovation, validating science-first firms like Avicanna.

Aduro Clean Technologies raises $20M for a key plant, navigating market jitters to fund its game-changing chemical recycling technology.

A strategic partnership aims to merge respiratory rentals with innovative hygiene products, promising better compliance and comfort for millions of CPAP users.

In a high-level diplomatic dinner, Argentina's ambassador showcased President Milei's sweeping reforms, signaling a new chapter for UK investment.

Danish water tech firm Aquaporin seeks urgent funding, warning of 77% dilution for shareholders as it races to secure its future and new technology.

CLO Virtual Fashion launches a Dongguan hub, integrating its massive digital fabric library to transform the global apparel supply chain from the source.

The VCT posts a marginal loss but shows second-half recovery, while navigating strategic exits and facing a pivotal shift in UK VCT tax policy.

With backing from AstraZeneca and Pfizer, Beijing’s Syneron Bio is using its AI-driven platform to develop novel drugs for cancer and chronic illness.

A publicly listed venture builder reports explosive growth and a radical new strategy: using a video game to democratize venture capital for everyone.

In a major move for the AI infrastructure race, TeraWulf and Fluidstack secure massive project financing for a 168 MW Texas facility, backed by Google.